[Effect of the GCP Directive on academic drug trials]
- PMID: 18761825
[Effect of the GCP Directive on academic drug trials]
Abstract
Since 2004, adherence to Good Clinical Practice has been mandatory for all clinical drug trials. This was new to the investigator-initiated trials. Our study showed no association between the implementation of the Directive and investigator or industry-initiated trials. However, a steady decline was observed over the entire period. Presumably, the introduction of GCP did not entail a decline because of the presence of GCP units at university hospitals. Thus, researchers can conduct clinical drug trials under the same regulations as drug companies.
Republished from
-
Effect of European Clinical Trials Directive on academic drug trials in Denmark: retrospective study of applications to the Danish Medicines Agency 1993-2006.BMJ. 2008 Jan 5;336(7634):33-5. doi: 10.1136/bmj.39401.470648.BE. Epub 2007 Dec 6. BMJ. 2008. PMID: 18063611 Free PMC article.